Page last updated: 2024-08-26

titanium nitride (tin) and Coronary Restenosis

titanium nitride (tin) has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balducelli, M; Bortone, AS; Colombo, A; Di Sciascio, G; Hehrlein, C; Kastrati, A; Moccetti, T; Waltenberger, J	1

Trials

1 trial(s) available for titanium nitride (tin) and Coronary Restenosis

Article	Year
A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8 Topics: Angioplasty, Balloon, Coronary; Chromium Alloys; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Europe; Humans; Kaplan-Meier Estimate; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Research Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome	2010

Article

Year

A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8

Topics: Angioplasty, Balloon, Coronary; Chromium Alloys; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Europe; Humans; Kaplan-Meier Estimate; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Research Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome

2010